Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV

Trends in Immunology

Volumn 37, Issue 3, 2016, Pages 233-243

  Rölle, Alexander ^a   Brodin, Petter ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adaptive NK cells; CD57; CMV; NK cell memory; NKG2C

Indexed keywords

NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; UNCLASSIFIED DRUG;

ADAPTATION; ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CELL EXPANSION; CYTOMEGALOVIRUS INFECTION; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE ADAPTATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; VIRUS INFECTION; ADVERSE EFFECTS; ANIMAL; CYTOMEGALOVIRUS; ENVIRONMENTAL EXPOSURE; EPIGENETIC REPRESSION; GENE EXPRESSION REGULATION; GENOTYPE ENVIRONMENT INTERACTION; IMMUNE SYSTEM; IMMUNOLOGY; VIROLOGY; VIRUS LATENCY;

ADAPTIVE IMMUNITY; ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENVIRONMENTAL EXPOSURE; EPIGENETIC REPRESSION; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; VIRUS LATENCY;

EID: 84959559396     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.01.005     Document Type: Review

References (85)

1. Roederer M., et al. The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell 2015, 161:387-403.
2. Brodin P., et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 2015, 160:37-47.
3. Svendsen A.J., et al. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ 2002, 324:264-266.
4. Horowitz A., et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 2013, 5:208ra145.
5. Brodin P., et al. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 2009, 30:143-149.
6. O'Leary J.G., et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006, 7:507-516.
7. Paust S., et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 2010, 11:1127-1135.
8. Peng H., et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 2013, 123:1444-1456.
9. Sun J.C., et al. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
10. Sun J.C., et al. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 2012, 209:947-954.
11. Madera S., Sun J.C. Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion. J. Immunol. 2015, 194:1408-1412.
12. Zawislak C.L., et al. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:6967-6972.
13. Beaulieu A.M., et al. The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol. 2014, 15:546-553.
14. Min-Oo G., et al. Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J. Exp. Med. 2014, 211:1289-1296.
15. Karo J.M., et al. The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells. Cell 2014, 159:94-107.
16. O'Sullivan T.E., et al. BNIP3- and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory. Immunity 2015, 43:331-342.
17. Cooper M., et al. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1915-1919.
18. Ni J., et al. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 2012, 209:2351-2365.
19. Keppel M.P., et al. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. J. Immunol. 2013, 190:4754-4762.
20. Leong J.W., et al. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol. Blood Marrow Transplant. 2014, 20:463-473.
21. Reeves R.K., et al. Antigen-specific NK cell memory in rhesus macaques. Nat. Immunol. 2015, 16:927-932.
22. Gumá M., et al. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
23. Monsiváis-Urenda A., et al. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 2010, 40:1418-1427.
24. Noyola D.E., et al. Dynamics of the NK-cell subset redistribution induced by cytomegalovirus infection in preterm infants. Hum. Immunol. 2015, 76:118-123.
25. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
26. Braud V.M., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799.
27. Lanier L.L., et al. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998, 8:693-701.
28. Kuijpers T.W., et al. Human NK cells can control CMV infection in the absence of T cells. Blood 2008, 112:914-915.
29. hi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14725-14732.
30. Della Chiesa M., et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?. Blood 2011, 119:399-410.
31. + NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 2012, 189:5082-5088.
32. + natural killer cells with potent function. Blood 2011, 119:2665-2674.
33. Davis Z.B., et al. Adaptive NK cell and KIR-expressing T cell responses are induced by CMV and are associated with protection against CMV reactivation after allogeneic donor hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 2015, 21:1653-1662.
34. -/- umbilical cord blood. J. Immunol. 2014, 192:1471-1479.
35. Noyola D.E., et al. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 2012, 42:3256-3266.
36. Muntasell A., et al. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur. J. Immunol. 2013, 43:3268-3278.
37. Goodier M.R., et al. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 2014, 124:2213-2222.
38. Gumá M., et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006, 194:38-41.
39. Brunetta E., et al. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2010, 24:27-34.
40. + individuals with high plasma viral load. AIDS Res. Hum. Retroviruses 2013, 29:84-88.
41. + NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma. J. Virol. 2007, 81:430-433.
42. Björkström N.K., et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with Hantavirus. J. Exp. Med. 2011, 208:13-21.
43. Petitdemange C., et al. Unconventional repertoire profile is imprinted during acute Chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 2011, 7:e1002268.
44. Oliviero B., et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009, 137:1151-1160.
45. + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2011, 42:447-457.
46. Saghafian-Hedengren S., et al. Epstein-Barr virus co-infection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J. Virol. 2013, 87:13446-13455.
47. + NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J. Immunol. 2014, 192:4492-4496.
48. Björkström N.K., et al. Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS ONE 2011, 6:e27664.
49. + NK cells associates with the development of specific de novo malignancies in liver-transplanted patients. J. Immunol. 2014, 192:503-511.
50. Petersen L., et al. The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus. Viral Immunol. 2009, 22:333-337.
51. + NK cells. J. Immunol. 2015, 194:2467-2471.
52. + population. Lancet 2015, 385:S45.
53. Khakoo S.I., Carrington M. KIR and disease: a model system or system of models?. Immunol. Rev. 2006, 214:186-201.
54. + NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells. J. Immunol. 2013, 191:2708-2716.
55. Béziat V., et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013, 121:2678-2888.
56. Charoudeh H.N., et al. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur. J. Immunol. 2013, 43:480-487.
57. + NK cells in TAP-deficient patients. Front. Immunol. 2015, 6:1-8.
58. + NK cell expansion. J. Clin. Invest. 2014, 124:5305-5316.
59. Prod'homme V., et al. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J. Immunol. 2012, 188:2794-2804.
60. Nattermann J., et al. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir. Ther. 2005, 10:95-107.
61. + natural killer cell function through presentation of a restricted peptide repertoire. Hum. Immunol. 2015, 76:578-586.
62. Magri G., et al. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011, 117:848-857.
63. + natural killer cells. Oncotarget 2015, 6:19930-19931.
64. Starbeck-Miller G.R., et al. IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J. Exp. Med. 2014, 211:105-120.
65. Simhadri V.R., et al. Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation. J. Allergy Clin. Immunol. 2014, 18:1190-1194.
66. + NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia 2015, Published online October 23, 2015. 10.1038/leu.2015.260.
67. Bhatnagar N., et al. FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32). Eur. J. Immunol. 2014, 44:3368-3379.
68. hi natural killer cells. PLoS Pathog. 2014, 10:e1004441.
69. Schlums H., et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015, 42:443-456.
70. Thomas R., et al. NKG2C deletion is a risk factor of HIV infection. AIDS Res. Hum. Retroviruses 2012, 28:844-851.
71. Siewiera J., et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog. 2013, 9:e1003257.
72. hi natural killer cells are effectors dependent on humoral antiviral immunity. J. Virol. 2013, 87:7717-7725.
73. bright NK cells against human cytomegalovirus. J. Immunol. 2015, 194:2715-2724.
74. Vanherberghen B., et al. Classification of human natural killer cells based on migration behavior and cytotoxic response. Blood 2013, 121:1326-1335.
75. Lönnqvist B., et al. Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection. Br. J. Haematol. 1986, 63:671-679.
76. Behrendt C.E., et al. Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol. Blood Marrow Transpl. 2009, 15:54-60.
77. Elmaagacli A.H., et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011, 118:1402-1412.
78. Green M.L., et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 2013, 122:1316-1324.
79. Ito S., et al. CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant. 2013, 48:1313-1316.
80. Hwang I., et al. Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions. Int. Immunol. 2012, 24:793-802.
81. Bryceson Y.T., et al. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006, 107:159-166.
82. Zhang T., et al. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J. Immunol. 2013, 190:1402-1406.
83. Zhou J., et al. An NK cell population lacking FcRγ is expanded in chronically infected HIV patients. J. Immunol. 2015, 194:4688-4697.
84. Lee J., et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 2015, 42:431-442.
85. White D.W., et al. Immune modulation during latent herpesvirus infection. Immunol. Rev. 2012, 245:189-208.